SUPPLEMENTARY APPENDIX

Online Supplementary Design and Methods
Gene expression profiling and data analysis
Total RNA was extracted using TRIZOL-LS (Invitrogen), treated with DNase and purified using the RNAeasy kit (Qiagen, Valencia, CA, USA). RNA quality was assessed by agarose gel electrophoresis and quantified using a NanoDrop 1000 spectrophotometer (NanoDrop, Wilmington, DE, USA). Microarray profiling was performed using Whole Human Genome Oligo microarrays (Agilent, Palo Alto, CA, USA) containing 41,000 distinct probes. The Quick Amp Labeling Kit, one-color kit (Agilent) was used to generate Cy3-labeled cRNA, which was then fragmented and hybridized to the microarray slides. Slides were scanned using a GenePix 4000B scanner (at 535 nm, 5 µm/pixel resolution) and the "GenePix Pro 6.0" software (Molecular Devices, Sunnyvale, CA, USA). Images were analyzed with Agilent Feature Extraction software (version 9.5.3.1) and the 75 th percentile processed signal of each array was used to normalize the data, allowing interarray comparisons. Complete microarray data sets have been deposited in the NCBI Gene Expression Omnibus and are accessible through GEO Series accession number GSE30896 (http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE30896).
After averaging replicated probes in the arrays, transcripts differentially expressed between bone marrow and peripheral blood chronic lymphocytic leukemia (CLL) cells were identified by a two-tailed paired t-test, with P values less than 0.05 indicating statistically significant differences. Transcripts showing at least a two-fold difference between bone marrow and peripheral blood averaged expression values were submitted to a functional classification analysis, using the online Database for Annotation, Visualization and Integrated Discovery (DAVID) version 6.7 (http://david.abcc.ncifcrf.gov/). Briefly, differentially expressed transcripts that were present at higher levels in bone marrow CLL cells than in peripheral blood CLL cells were first classified into functionally-related groups based on annotated Gene Ontology terms; the enrichment of specific terms in the list of differentially expressed transcripts was then statistically evaluated by comparing their observed frequency in the whole human genome. To allow the visualization of selected differentially expressed genes, microarray transcript levels were used to generate a heatmap (row-normalized sorting), using the HeatMap Builder software, available at http://ashleylab.stanford.edu/tools_scripts.html.
Quantitative real-time reverse transcriptase polymerase chain reaction analysis
RNA (500 ng) was used to produce single-stranded cDNA with the High Capacity cDNA Archive Kit (Applied BioSystems, Foster City, CA, USA), following the manufacturer's instructions. Pre-designed TaqMan probes and MasterMix (Applied Biosystems) were used to quantify the expression of AURKA, AURKB, BIRC5, CDK6, and GAPDH (reference gene) in a 7300 Real-Time PCR System (Applied Biosystems). The fold-difference in gene expression was calculated using the formula 2-ΔΔCt, where the ΔCt value was obtained by subtracting the mean Ct of the reference gene from the mean Ct of the target gene for each sample; the ΔΔCt value was calculated by subtracting, in each sample, the ΔCt of one peripheral blood CLL sample that was used as a calibrator.
Analysis of cell cycle, proliferation and apoptosis
MEC1 and EHEB cells were synchronized for 18 h with 2 mM thymidine (Sigma-Aldrich), washed with phosphatebuffered saline, cultured for 9 h in complete RPMI, and treated a second time with 2 mM thymidine for an additional 12 h. After the second incubation in thymidine, cells were washed twice in phosphate-buffered saline to release the thymidine block and resuspended in complete RPMI. Cells were harvested after 8 and 24 h, resuspended in DNA staining buffer (0.1% sodium citrate; 0.1% Triton X-100 and 50 μg/mL propidium iodide) by vortexing, incubated for 30 min at 4°C and analyzed for DNA content on a FACSCalibur cytometer (BD Biosciences). Cell doublets and debris were excluded from further analysis by gating individual cells in peak area versus peak width plots.
For analysis of proliferation, 5-bromo-2-deoxyuridine (BrdU) 10 μM was added to synchronized or unsynchronized MEC1 or EHEB cells for 1 h prior to harvesting. In experiments with primary CLL cells, BrdU was added after 48 h of stimulation with CpG-oligonucleotide/interleukin-2 and the cells were cultured for another 18 h before harvesting. Cells were washed with phosphate-buffered saline and fixed overnight at -20°C in 70% ethanol. Cells were permeabilized with 2N HCl and 0.5% Triton X-100 for 30 min at room temperature and neutralized with 0.1M Na2B4O7 x 10H2O, pH 8.5. Incorporated BrdU was detected with anti-BrdU-fluorescein isothiocyanate (FITC) antibody (BD Biosciences) and flow cytometry.
The percentage of viable cells was determined by staining with annexin-A5-FITC conjugate (Nexins Research, Kattendijke, The Netherlands) and propidium iodide. Data were analyzed on a FACSCalibur flow cytometer with the CellQuest software (BD Biosciences). Viable cells are annexin V/propidium iodide double-negative.
